CClinicalTrials.gg
Status unknownNCT02165696LYMPHATICUpdated Jun 17, 2014

Compression Bandaging and Manual Lymph Drainage in Women With Lymphedema

An interventional study of Multimodal treatment: compression bandaging and manual lymph drainage. and Manual lymph drainage in Arm Lymphedema After Breast Cancer, sponsored by University of Malaga. Status unknown at 1 site in Spain. Open to female participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2014-06-17.

Sponsored by University of Malaga · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2014), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
Female
01

Study summary

Lymphedema is the result of accumulation of fluid and other elements in tissue spaces because of an imbalance between the production of fluid interstitial and transport. Lymphedema can cause significant physical and psychological morbidity. Prevalence of lymphedema in patients after breast cancer surgery is 12-60% and the incidence is 12-26%.Psychological and social consequences of secondary lymphedema related breast cancer have been little recognized and documented. Although, it have performed many studies related secondary lymphedema it not found sufficient evidence in the literature to suggest the most effective treatment. There is some evidence suggesting that compression therapy and manual lymphatic drainage can improve lymphedema but more studies are needed. The aim of this research is to to evaluate the clinical effect of multimodal treatment (compression bandaging and manual lymph drainage) versus applying manual lymphatic drainage in women with arm lymphedema after breast cancer surgery.

Read the detailed description

This study has two sub research: a quantitative approach and a qualitative approach. The research will be carried out by a multicenter way

Quantitative approach consist in carried out a single-blind randomized controlled trial of 44 women with arm lymphedema. Patients will be distributed in two intervention groups by a randomized way. Participants will be given his assignment by closed envelope. Both treatments will be administered five days a week for six weeks. The experimental group (n=22) will receive multimodal treatment: combination of manual lymphatic drainage and compression bandaging. The control group (n=22) only will receive manual lymphatic drainage. We want to determinate the effect on volume arm decrease, quality of life, level of hand strength, degree of pain, fatigue level, and state of anxiety and depression. The influence on the lymphedema will be analyzed with lower limbs strength, physical activity, lung function, respiratory muscle strength by maximal inspiratory and expiratory pressure measurements (MIP and MEP) and cardiorespiratory functional capacity. Patients adherence will be analyzed by a smartphone.

Qualitative apprach: to know the perceptions and experiences of the participants in both interventions groups through a qualitative descriptive study. Data will be obtained with semi-structured depth interview.

02

Conditions studied

  • Arm Lymphedema After Breast Cancer

Keywords

  • compression bandage, manual lymphatic drainage, lymphedema, breast cancer, qualitative research.
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 44 is below the median of 72 across 9,302 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

University of Malaga is the lead sponsor of 118 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women between 45 and 65 years with secondary lymphedema in upper limb after breast cancer surgery.
  • Cancer stages I-III according to TNM classification of the American Joint Committee on Cancer.

Exclusion criteria

Exclusion Criteria:

  • To have received lymphedema treatment previously.
  • To be treated by radiation therapy or chemotherapy.
  • Distant metastases or local recurrence of cancer.
  • Infectious signs in the upper limb with lymphedema.
  • Uncontrolled hypertension.
  • Heart disease.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
44 participants (estimated)

Study arms

  • Experimental
    Manual lymphatic drainage and compression bandaging

    Experimental group: 30 minutes and one hour maximum time of manual lymphatic drainage and compression bandaging with multilayer inelastic bandages with low extensibility. It is possible to apply bandages two or three times per week. Also, an elastic bandage is also held in hand fingers with slight compression and other protective bandage is used in skin. The treatment will be carried out for six weeks five days a week

    Other: Multimodal treatment: compression bandaging and manual lymph drainage.

  • Active comparator
    Manual lymphatic drainage

    Control group: 30 minutes and one hour maximum time of manual lymphatic drainage. The treatment will be carried out for six weeks five days a week.

    Other: Manual lymph drainage

Interventions

  • OtherMultimodal treatment: compression bandaging and manual lymph drainage.

    30 minutes and one hour maximum time of manual lymphatic drainage and compression bandaging with multilayer inelastic bandages with low extensibility. It is possible to apply bandages two or three times per week. Also, an elastic bandage is also held in hand fingers with slight compression and other protective bandage is used in skin. The treatment will be carried out for six weeks five days a week

    Also known as: Multimodal treatment

  • OtherManual lymph drainage

    30 minutes and one hour maximum time of manual lymphatic drainage. The treatment will be carried out for six weeks five days a week.

06

What researchers measure

Primary outcomes

  1. Perimetry

    Arm volume is measured with perimetry through truncation of cones formula

    Time frame: Baseline, 6 weeks and 12 weeks

Secondary outcomes

  1. Handgrip strength

    Handgrip strength will be determined using hydraulic hand dynamometer "JAMAR"

    Time frame: Baseline, 6 weeks and 12 weeks

  2. Multiple sit-to-stant test

    Multiple sit-to-stant test will be used to evaluate lower limbs strength.

    Time frame: Baseline, 6 weeks and 12 weeks

  3. Degree of pain

    The degree of pain in the affected side with lymphedema will be measured by digital algometer "Commander ™"

    Time frame: Baseline, 6 weeks and 12 weeks

  4. Pulmonary function test

    Simple spirometry to measure lung function with a spirometer "DATOSPIR120"

    Time frame: Baseline, 6 weeks and 12 weeks

  5. Maximal inspiratory pressures (MIP) and maximal expiratory pressures (MEP)

    The strength of the respiratory muscles is measured through a digital manovacuometer (DATOSPIR120)

    Time frame: Baseline, 6 weeks and 12 weeks

  6. Six-minute walking test

    Cardiorespiratory functional capacity as measured with six-minute walking test.

    Time frame: Baseline, 6 weeks and 12 weeks

  7. FACT-B+4 questionnaire

    FACT-B+4 questionnaire to measure quality of life in patients with breast cancer and lymphedema. Alpha of cronbach: 0,52-0,92

    Time frame: Baseline, 6 weeks and 12 weeks

  8. EORTIC-QLQ-C30 questionnaire

    EORTIC-QLQ-C30 questionnaire measures the quality of life in cancer. Alpha of cronbach: 0,52 y 0,89

    Time frame: Baseline, 6 weeks and 12 weeks

  9. QLQ BR23 questionnaire

    QLQ BR23 questionnaire to know quality of life in patients with breast cancer. Alpha of cronbach: 0,48 y 0,94

    Time frame: Baseline, 6 weeks and 12 weeks

  10. HADS questionnaire

    HADS questionnaire to measure depression and anxiety. Alpha of cronbach: 0´8-0´76

    Time frame: Baseline, 6 weeks and 12 weeks

  11. QuickPIPPER questionnaire

    QuickPIPPER questionnaire measures the level of fatigue in breast cancer. Alpha of cronbach: 0,730- 0,961

    Time frame: Baseline, 6 weeks and 12 weeks

  12. The short version of the IPAQ

    The short version of the IPAQ questionnaire for physical activity level. Alpha of cronbach: 0,75

    Time frame: Baseline, 6 weeks and 12 weeks

  13. Qualitative measures

    Data collection was carried out through an interview in-depth semi-structured. The dimensions of the study were developed based on bibliography and objectives of the study: perceptions and experiences with multimodal treatment, ways of living with lymphedema, life style, Physical activity and exercise.

    Time frame: 6 weeks

  14. Smartphone-based application

    Smartphone-based application to analyze the treatment adherence of the participants

    Time frame: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks, 6 weeks

07

Study locations

1 site
  • University of Málaga
    Málaga, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 17, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02165696
Lead sponsor
University of Malaga
Responsible party
Rocío Martín Valero (Ph D, University of Malaga) — Principal investigator
First posted
Jun 17, 2014
Start date
Sep 2014
Primary completion
Dec 2015 (estimated)
Completion
Dec 2015 (estimated)
Last update
Jun 17, 2014

Study contacts

Martín-Valero R., Ph D
Contact
rovalemas@gmail.com
34 657834413

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion